ouabain has been researched along with Anemia, Fanconi in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Keck, JL; Manthei, KA; Voter, AF | 1 |
Hwang, M; Hwang, SK; Jun, DW; Kim, HJ; Kim, S; Lee, CH | 1 |
2 other study(ies) available for ouabain and Anemia, Fanconi
Article | Year |
---|---|
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
Topics: Antineoplastic Agents; DNA Damage; DNA Helicases; DNA Repair; Drug Screening Assays, Antitumor; Fanconi Anemia; High-Throughput Screening Assays; Humans; Multiprotein Complexes; Protein Interaction Maps; RecQ Helicases | 2016 |
Ouabain, a cardiac glycoside, inhibits the Fanconi anemia/BRCA pathway activated by DNA interstrand cross-linking agents.
Topics: Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Survival; Cisplatin; Fanconi Anemia; Fluorescent Antibody Technique; Humans; Mitomycin; Ouabain; Signal Transduction; Sodium-Potassium-Exchanging ATPase | 2013 |